The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines

Innovative therapies in cervical cancer (CC) remain a priority. Recent data indicate that human immunodeficiency virus (HIV)-protease inhibitors used in highly active antiretroviral therapy can exert direct antitumor activities also in HIV-free preclinical and clinical models. The aim of the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandiera, Elisabetta, Todeschini, Paola, Romani, Chiara, Zanotti, Laura, Erba, Eugenio, Colmegna, Benedetta, Bignotti, Eliana, Santin, Alessandro Davide, Sartori, Enrico, Odicino, Franco Edoardo, Pecorelli, Sergio, Tassi, Renata Alessandra, Ravaggi, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038480/
https://www.ncbi.nlm.nih.gov/pubmed/27698818
http://dx.doi.org/10.3892/ol.2016.5008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038480/
https://www.ncbi.nlm.nih.gov/pubmed/27698818
http://dx.doi.org/10.3892/ol.2016.5008

Ejemplares similares